According to the research report titled ‘Europe Vascular Graft Market Forecast 2027 By End-use, By Application, By Raw Material, Research Report, Country Outlook, COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share’, available with MarketStudyReport, Europe vascular graft market is expected to be remunerated at USD 928 million by 2027. 

The growing elderly population in the region, and rising cases of chronic infections like atherosclerosis and diabetes are catalyzing the growth of Europe vascular graft industry.

Request sample copy of this report: https://www.marketstudyreport.com/request-a-sample/4037687/

Additionally, significant technological developments and continual improvements in the present vascular graft manufacturing technologies through research & development, in consort with non-invasive nature of the procedure are propelling the market growth. 

On the other hand, concerns pertaining to vascular graft infections is the major challenge faced by the industry.

Based on application spectrum, the market can be classified into hemodialysis access, endovascular aneurysm repair (Abdominal Aortic Aneurysms repair and Thoracic Aortic Aneurysm repair), and peripheral vascular repair. Among these, the endovascular aneurysm repair segment was valued at USD 260 million in 2020 and is projected to garner significant traction through 2027, attributed to the highly non-invasiveness nature of the procedure with faster recovery period and minimal post-surgery scars, making it ideal for abdominal aortic aneurysm treatment. 

The bifurcation of Europe vascular graft market concerning raw materials comprises biosynthetic grafts, EPTFE grafts, polyester grafts, and polyurethane grafts. As per the report, the polyester graft segment is expected to rise at a CAGR of 6.1% through 2027, owing to the current technological innovations concerning raw materials, and the utilization of collagen and polyester for biosynthetic grafts creation. Additionally, characteristics like higher blood compatibility, and longer durability lead to a surge in
demand.

Analyzing the end-use scope, the industry segmentation includes ambulatory surgical centers, hospitals, and others. The hospital segment was responsible for 62.1% regional market share in 2020 and is expected to grow substantially through 2027. One of the primary reasons is that hospitals offer various medical interventions and approaches for individuals with chronic conditions like cardiothoracic and hemodialysis.

Talking about the regional outlook, UK vascular graft industry was worth USD 151.6 million in 2020 and is anticipated to expand at 6.9% CAGR through 2027, due to the growing percentage of the elderly population in the region, and the rising preference for minimally invasive procedures.

The topmost organizations influencing Europe vascular graft market trends include CryoLife, Inc., W.L. Gore & Associates, Inc., Medtronic plc, Getinge Group, B. Braun Melsungen AG, Becton Dickinson and Company, Cook Medical, LeMaitre Vascular, Inc., Terumo Corporation, and Endologix LLC.